Viewing nowDaewoong Rosuvastatin Tablet 2.5 mg (Rosuvastatin Calcium (unrefined))
Rosuvastatin Calcium Micronized 2.6mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 202202878 · Approved 2022.07.12 · Insurance code 641607730
Treatment of primary hypercholesterolemia and mixed hyperlipidemia
This medication is used to treat primary hypercholesterolemia and mixed dyslipidemia. It is prescribed to supplement dietary changes when diet and exercise alone are insufficient. It is particularly effective for patients with heterozygous familial hypercholesterolemia (type IIa). It helps lower cholesterol levels to maintain vascular health. Therefore, it contributes to the prevention of cardiovascular diseases by improving lipid abnormalities.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 2.5 or 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams once daily. Elderly patients: No dosage adjustment is required. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 2.5 or5 milligrams. Administration of a 40 milligrams dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 2.5 or5 milligrams. Administration of a 40 milligrams dose of this medicine is contraindicated in some of these patients.
This medication should not be administered to certain patients. For example, patients with allergies to this drug, those with severely impaired liver function, patients with muscular diseases, and those taking specific medications should not use this drug. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraception to lower the risk of pregnancy. This medication may affect liver function; therefore, patients with a history of liver disease or those consuming alcohol heavily should undergo liver function tests before and during treatment. If symptoms such as muscle pain or weakness occur, consult a doctor immediately, and in severe cases, the medication may need to be discontinued. Particularly, patients at high risk for muscular diseases require regular testing. This medication contains lactose, so patients with certain genetic disorders like lactose intolerance should not take it. This drug may interact with other medications, so it is essential to inform the doctor or pharmacist of any other medications currently being taken. Co-administration with some drugs can increase the concentration of this medication and elevate the risk of side effects. The safety of this medication has not been established in pregnant or breastfeeding women, thus it should be avoided, and women planning for pregnancy should consult healthcare professionals before use. In case of overdose, there is no specific antidote, so it is crucial to visit a medical institution for proper treatment immediately and to conduct tests to check for liver function and muscle damage. This medication is known not to significantly affect driving or operating machinery; however, caution is needed as dizziness may occur.
Dyspepsia, pruritus, immune thrombocytopenic purpura, facial edema, herpes zoster, vulvar pruritus, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced erythrodermic drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, headache, dizziness, increased ALT, chest pain, cough, myalgia, increased CK, constipation, increased AST, weakness, joint pain, fatigue, numbness, altered sensation, chest discomfort, nausea, abdominal pain, diarrhea, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 2.6mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.